FA
BLUE

FCG Advisors’s bluebird bio BLUE Stock Holding History

FCG Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$540K Sell
772
-2
-0.3% -$1.56K 0.13% 89
2020
Q2 		$612K Buy
+774
New +$584K 0.16% 70

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

FCG Advisors's BLUE Position: Q3 2020 in Review

FCG Advisors reduced its bluebird bio (BLUE) stake by 0.26% in Q3 2020, selling an estimated $1.56K and leaving 772 shares worth $540K. The position accounts for 0.13% of the portfolio, ranked #89.

FCG Advisors first reported a position in BLUE in Q2 2020 and has held it in 2 quarters since. The position peaked at $612K in Q2 2020. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • FCG Advisors held 772 shares of bluebird bio worth $540K as of Q3 2020.
  • FCG Advisors sold 2 bluebird bio shares in Q3 2020, an estimated $1.56K.
  • bluebird bio made up 0.13% of FCG Advisors's portfolio in Q3 2020, its #89 holding.
  • FCG Advisors first reported a position in bluebird bio in Q2 2020 and has held it in 2 quarters since.
  • FCG Advisors's bluebird bio position peaked at $612K in Q2 2020.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on FCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.